- Home
- About
- Find staff
- Stig Palm
Stig Palm
Researcher
Department of Medical Radiation Sciences-
A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical
trial
Emma Aneheim, Tom Bäck, Holger Jensen, Stig Palm, Sture Lindegren
PLOS ONE - 2024 -
Technical note: Errors introduced when using Dose Voxel Kernels for estimating absorbed dose from radiopharmaceutical therapies involving alpha
emitters
Jonathan Tranel, Stig Palm, Felix Y. Feng, Sara St James, Thomas A. Hope
MEDICAL PHYSICS - 2024 -
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In
Vitro
Tom Bäck, Per Albertsson, Emma Aneheim, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Stig Palm
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS - 2024 -
Astatine-211 based radionuclide therapy: Current clinical trial
landscape
Per Albertsson, Tom Bäck, Karin Bergmark, Andreas Hallqvist, Mia Johansson, Emma Aneheim, Sture Lindegren, Chiara Timperanza, K. Smerud, Stig Palm
Frontiers in Medicine - 2023 -
Estimating the risk for secondary cancer following targeted alpha therapy with astatine-211 intraperitoneal
radioimmunotherapy.
Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2022 -
Impact of radiopharmaceutical therapy (Lu-177, Ac-225) microdistribution in a cancer-associated fibroblasts
model
J. Tranel, Stig Palm, S. A. Graves, F. Y. Feng, T. A. Hope
EJNMMI Physics - 2022 -
Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian
cancer
Stig Palm, Tom Bäck, Emma Aneheim, Andreas Hallqvist, Ragnar Hultborn, Lars Jacobsson, H. Jensen, Sture Lindegren, Per Albertsson
Translational Oncology - 2021 -
Realizing Clinical Trials with Astatine-211: The Chemistry
Infrastructure
Sture Lindegren, Per Albertsson, Tom Bäck, H. Jensen, Stig Palm, Emma Aneheim
Cancer Biotherapy and Radiopharmaceuticals - 2020 -
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone
microtumors
Tom Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, H. Jensen, T. Olafsen, P. J. Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, A. M. Wu, Karin Welén
Ejnmmi Research - 2020 -
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo
Behavior
Y. Dekempeneer, Tom Bäck, Emma Aneheim, H. Jensen, J. Puttemans, C. Xavier, M. Keyaerts, Stig Palm, Per Albertsson, T. Lahoutte, V. Caveliers, Sture Lindegren, M. D'Huyvetter
Molecular Pharmaceutics - 2019 -
Radiosensitivity: Gender and Order of Administration of G-CSF, An Experimental Study in
Mice
Ragnar Hultborn, Per Albertsson, Susanne Ottosson, Elisabet Warnhammar, Åsa Palm, Stig Palm, Kerstin Elmroth
Radiation Research - 2019 -
Towards elucidating the radiochemistry of astatine - Behavior in
chloroform
Emma Aneheim, Stig Palm, H. Jensen, C. Ekberg, Per Albertsson, Sture Lindegren
Scientific Reports - 2019 -
Intraperitoneal alpha-Emitting Radioimmunotherapy with At-211 in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose
Estimations
Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, H. Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm, Per Albertsson
Journal of Nuclear Medicine - 2019 -
Astatine-211: The Chemistry
Infrastructure.
Sture Lindegren, Tom Bäck, Stig Palm, Holger Jensen, Per Albertsson, Emma Aneheim
Journal of Medical Imaging and Radiation Sciences - 2019 -
Intraperitoneal Alpha-emitting Radio Immunotherapy with Astatine-211 in Relapsed Ovarian Cancer; Long-term Follow-up with Individual Absorbed Dose
Estimations.
Andreas Hallqvist, Per Albertsson, Ragnar Hultborn, Stig Palm, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, Holger Jensen, Lars Jacobsson
Journal of Medical Imaging and Radiation Sciences - 2019 -
Estimation of Long-term Risks for Cancer Induction following Adjuvant Targeted Alpha Therapy with Curative
Intent.
Stig Palm, Andreas Hallqvist, Emma Aneheim, Tom Bäck, Mia Johansson, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Per Albertsson
Journal of Medical Imaging and Radiation Sciences - 2019 -
Quantified Cell Binding of Astatinated Immunoconjugates onOvarian Cancer Cell Spheroids by Alpha Camera
Imaging.
Tom Bäck, M Verhoeven, Emma Aneheim, Per Albertsson, Stig Palm, Sture Lindegren, Holger Jensen
Journal of Medical Imaging and Radiation Sciences - 2019 -
ICRP Publication 140: Radiological Protection in Therapy with
Radiopharmaceuticals.
Y Yonekura, S Mattsson, G Flux, W E Bolch, L T Dauer, D R Fisher, M Lassmann, Stig Palm, M Hosono, M Doruff, C Divgi, P Zanzonico
Annals of the ICRP - 2019 -
Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor
Sizes.
Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2018 -
Clinical alpha-particle
dosimetry.
Stig Palm
Physica medica - 2018 -
Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and
meta-analysis
Per Albertsson, Charlotte Alverbratt, Ann Liljegren, Emil Björkander, Annika Strandell, Ola Samuelsson, Stig Palm, Andreas Hallqvist
Critical reviews in oncology/hematology - 2018 -
Preclinical Experience in Alpha Particle
Dosimetry.
Stig Palm
European Journal of Nuclear Medicine and Molecular Imaging - 2017 -
Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated alpha-Radioimmunotherapy with At-211-MX35-F(ab')(2): Influence of Absorbed Tumor Dose and Effect on Long-Term
Survival
Tom Bäck, N. Chouin, Sture Lindegren, Helena Kahu, H. Jensen, Per Albertsson, Stig Palm
Journal of Nuclear Medicine - 2017 -
Therapeutic efficacy of alpha-radioimmunotherapy with different activity levels of the Bi-213-labeled monoclonal antibody MX35 in an ovarian cancer
model
Anna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, Ragnar Hultborn, Stig Palm, Lars Jacobsson, A. Morgenstern, F. Bruchertseifer, Per Albertsson, Sture Lindegren
EJNMMI Research - 2017 -
Biokinetic modeling and dosimetry for optimizing intraperitoneal radioimmunotherapy of ovarian cancer
microtumors.
Stig Palm, Tom Bäck, Börje Haraldsson, Lars Jacobsson, Sture Lindegren, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2016 -
Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide
Immunoconjugates
Emma Aneheim, Anna Gustafsson, Per Albertsson, Tom Bäck, Holger Jensen, Stig Palm, Sofia Svedhem, Sture Lindegren
Bioconjugate chemistry - 2016 -
MIRD monograph - Radiobiology and dosimetry for radiopharmaceutical therapy with alpha-particle
emitters.
G Sgouros, Stig Palm, Tom Bäck, Barry Allen, A. Bertrand Brill, Darrell R. Fisher, Robert F. Hobbs, Roger W. Howell, Michael R. McDevitt, Ruby F. Meredith, Brian W. Miller, John C. Roeske, Stavroula Sofou, Hong Song, Julien Torgue, Michael R. Zalutsky
2015 -
Nuclear Medicine Physics - a handbook for teachers and
students.
Stig Palm, GL Poli
2015 -
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer
Patients.
Elin Cederkrantz, Håkan Andersson, Peter Bernhardt, Thomas Backhaus, Ragnar Hultborn, Lars Jacobsson, Holger Jensen, Sture Lindegren, Michael Ljungberg, Tobias Magnander, Stig Palm, Per Albertsson
International journal of radiation oncology, biology, physics - 2015 -
Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version
Rebmab200.
Sture Lindegren, Luciana N S Andrade, Tom Bäck, Camila Maria L Machado, Bruno Brasil Horta, Carlos Buchpiguel, Ana Maria Moro, Oswaldo Keith Okamoto, Lars Jacobsson, Elin Cederkrantz, Kohshin Washiyama, Emma Aneheim, Stig Palm, Holger Jensen, Maria Carolina B Tuma, Roger Chammas, Ragnar Hultborn, Per Albertsson
PloS one - 2015 -
Automated astatination of biomolecules--a stepping stone towards multicenter clinical
trials.
Emma Aneheim, Per Albertsson, Tom Bäck, Holger Jensen, Stig Palm, Sture Lindegren
Scientific reports - 2015 -
Modelling the biokinetics of intra-peritoneally administered targeted alpha therapy on patients for improved
dosimetry.
Stig Palm, Tom Bäck, Sture Lindegren, Holger Jensen, Per Albertsson, Lars Jacobsson
Journal of Nuclear Medicine - 2014 -
Effective dose of intraperitoneal α-radioimmunotherapy with
211At.
Elin Cederkrantz, Tom Bäck, Lars Jacobsson, Holger Jensen, Sture Lindegren, Stig Palm, Per Albertsson
Journal of Nuclear Medicine - 2014 -
Image-based small-scale 3D-dosimetry in targeted alpha therapy using voxel dose-point kernels and alpha camera imaging of serial tissue
sections.
Tom Bäck, Nicolas Chouin, Sture Lindegren, Holger Jensen, Per Albertsson, Stig Palm
Journal of Nuclear Medicine - 2014 -
Polylysine-based Effector Molecules and Clearing Agents for Pretargeting Systems in Therapy and Imaging – Increasing Avidity and Specific Activity and Providing Many Ways to Optimize In Vivo
Distribution.
Anna Gustafsson-Lutz, Tom Bäck, Per Albertsson, Stig Palm, A Morgenstern, F Bruchertseifer, Sture Lindegren
European Journal of Nuclear Medicine and Molecular Imaging - 2014 -
Intra-tumoral dose distributions after experimental targeted alpha therapy by Alpha-Camera
imaging.
Nicolas Chouin, Stig Palm, Sture Lindegren, Holger Jensen, Per Albertsson, Tom Bäck
European Journal of Nuclear Medicine and Molecular Imaging - 2014 -
At-211
dosimetry.
Stig Palm
European Journal of Nuclear Medicine and Molecular Imaging - 2014 -
PET/CT atlas on quality Control and image artefacts. Human Health series no.
27.
Stig Palm, GL Poli, H Delis
2014 -
Quantitative Nuclear Medicine Imaging: Concepts, Requirements and Methods. Human Health Reports
#9.
Stig Palm, GL Poli
2014 -
Accuracy and repeatability of quantitative I-131 SPECT: Phantom design and benchmark
results.
N Anizan, I Buvat, E Frey, A Green, M Lassmann, M Ljungberg, Stig Palm, B Zimmerman
Journal of Nuclear Medicine - 2013 -
Ex Vivo Activity Quantification in Micrometastases at the Cellular Scale Using the α-Camera
Technique.
Nicolas Chouin, Sture Lindegren, Sofia Frost, Holger Jensen, Per Albertsson, Ragnar Hultborn, Stig Palm, Lars Jacobsson, Tom Bäck
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2013 -
Calibration of Traceable Solid Mock I-131 Phantoms Used in an International SPECT Image Quantification
Comparison.
B Zimmerman, L Pibida, L King, D Bergeron, M Mille, Stig Palm
European Journal of Nuclear Medicine and Molecular Imaging - 2012 -
Tumor Growth of Subcutaneous Xenografts after Repeated Alpha-Radioimmunotherapy with Astatine-211: What Absorbed Dose is Required to Treat Solid Tumors with Alpha-particle
Emitters?
Tom Bäck, Nicolas Chouin, Sture Lindegren, Holger Jensen, Stig Palm, Per Albertsson
European Journal of Nuclear Medicine and Molecular Imaging - 2012 -
Patient-specific alpha-particle
dosimetry
Stig Palm, Jörgen Elgqvist, Lars Jacobsson
Current radiopharmaceuticals - 2011 -
Statistical and dosimetric analysis of the penetration of antibody fragments F(ab')2 radiolabeled with 211At within subcutaneous
tumors.
Nicolas Chouin, Tom Bäck, M Bardies, Sofia Frost, Sture Lindegren, Stig Palm, O Press, Lars Jacobsson
Journal of Nuclear Medicine - 2011 -
International symposium on Standards, Applications and Quality Assurance in Medical Radiation Dosimetry
(IDOS).
Stig Palm
2011 -
EANM Dosimetry Committee guidance document: good practice of clinical dosimetry
reporting.
M Lassmann, C Chiesa, G Flux, Stig Palm, M Bardiès
European journal of nuclear medicine and molecular imaging - 2011 -
Clinical Training of Medical Physicists Specializing in Nuclear Medicine. Training Course Series No. 50. ISSN
1018-5518.
D McLean, Stig Palm, MP Dias
2011 -
Atlas on QC/QA and artifacts of PET and PET/CT
systems.
Stig Palm, S Holm, C Robilotta, A Kesner, M Dondi, O Mawlawi
Journal of Nuclear Medicine - 2010 -
IAEA supports training in internal
dosimetry.
Stig Palm
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2010 -
Results of an international comparison of
57Co.
B E Zimmerman, Stig Palm
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine - 2010 -
Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic
cancer.
Stavroula Sofou, Richard Enmon, Stig Palm, Barry Kappel, Pat Zanzonico, Michael R McDevitt, David A Scheinberg, George Sgouros
Journal of liposome research - 2010 -
Planning a Clinical PET Centre. Human Health Series No.
11
M Dondi, Stig Palm, M Haji-Saied
2010 -
MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide
therapy.
George Sgouros, John C Roeske, Michael R McDevitt, Stig Palm, Barry J Allen, Darrell R Fisher, A Bertrand Brill, Hong Song, Roger W Howell, Gamal Akabani
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2010 -
Ovarian cancer: background and clinical
perspectives
Jörgen Elgqvist, Ragnar Hultborn, Sture Lindegren, Stig Palm
Targeted Radionuclide Therapy - 2010 -
Quality Assurance for SPECT systems. Human Health Series No.
6.
M Dondi, Stig Palm
2009 -
Quality Assurance for PET and PET/CT Systems. Human Health Series No.
1.
M Dondi, D McLean, Stig Palm
2009 -
MIRD Pamphlet No. 22 - Radiobiology and Dosimetry of Alpha-particle Emitters for Targeted Radionuclide
Therapy.
G Sgouros, JC Roeske, MR McDevitt, Stig Palm, BJ Allen, DR Fisher, AB Brill, H Song, RW Howell, G Akabani
2009 -
Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I
study.
Håkan Andersson, Elin Cederkrantz, Tom Bäck, Chaitanya Divgi, Jörgen Elgqvist, Jakob Himmelman, György Horvath, Lars Jacobsson, Holger Jensen, Sture Lindegren, Stig Palm, Ragnar Hultborn
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2009 -
Intraperitoneal alpha-radioimmunotherapy of ovarian cancer – pharmacokinetics and dosimetry of 211At-MX35 F(ab’)2 in a phase I
study.
E Haglund, Håkan Andersson, Tom Bäck, C Divgi, Jörgen Elgqvist, Sofia Frost, Jakob Himmelman, György Horvath, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2008 -
Intraperitoneal alpha-radioimmunotherapy of ovarian cancer – pharmacokinetics and dosimetry of 211At-MX35 F(ab’)2 in a phase I
study.
E Haglund, Håkan Andersson, Tom Bäck, C Divgi, Jörgen Elgqvist, Sofia Frost, Jakob Himmelman, György Horvath, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
Radiotherapy and Oncology - 2008 -
IAEA sets new standards for QA/QC of PET-CT
scanners.
G El Fakhri, R Fulton, J Gray, M Marengo, B Zimmerman, Stig Palm, D McLean, M Dondi
European Journal of Nuclear Medicine and Molecular Imaging - 2008 -
Differences in radiosensitivity between three HER2 overexpressing cell
lines.
Ann-Charlott Steffen, Lovisa Göstring, Vladimir Tolmachev, Stig Palm, Bo Stenerlöw, Jörgen Carlsson
European journal of nuclear medicine and molecular imaging - 2008 -
Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude
mice.
Stig Palm, Tom Bäck, Ingela Claesson, Anna Danielsson, Jörgen Elgqvist, Sofia Frost, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Lars Jacobsson
International journal of radiation oncology, biology, physics - 2007 -
Biodistribution of free 225Ac in nude
mice.
Stig Palm, Tom Bäck, Jörgen Elgqvist, Ragnar Hultborn, Helena Kahu, Sture Lindegren, Elisabet Warnhammar, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2006 -
Pharmacokinetics and dosimetry of 211At-MX35 F(ab')2 in therapy of ovarian cancer - preliminary results from an ongoing phase I
study.
Ragnar Hultborn, Håkan Andersson, Tom Bäck, C Divgi, Jörgen Elgqvist, Jakob Himmelman, György Horvath, Holger Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2006 -
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35
F(ab')2.
Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt, Tom Bäck, Ingela Claesson, Ragnar Hultborn, Holger Jensen, Bengt R Johansson, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
International journal of radiation oncology, biology, physics - 2006 -
Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed
dose.
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ingela Claesson, Ragnar Hultborn, Holger Jensen, Bengt R Johansson, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2006 -
Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and
myelotoxicity
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ingela Claesson, Ragnar Hultborn, H. Jensen, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
Nucl Med Biol - 2006 -
Alpha-particle emitter [211At] mediated anticancer efficacy of Trastuzumab: Single-dose and fractionated 211At-Herceptin therapy in a nude mouse ovarian carcinoma
model.
Stig Palm, Tom Bäck, Ingela Claesson, Jörgen Elgqvist, Ragnar Hultborn, Börje Karlsson, Sture Lindegren, Lars Jacobsson
Journal of Nuclear Medicine - 2005 -
211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in
vivo
Tom Bäck, Håkan Andersson, C. R. Divgi, Ragnar Hultborn, H. Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
J Nucl Med - 2005 -
Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody
MX35
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ragnar Hultborn, H. Jensen, Börje Karlsson, Sture Lindegren, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
J Nucl Med - 2005 -
Antitumor effect of At-211-radioimmunotherapy on subcutaneous human ovarian cancer xenografts: Evaluation of RBE of an alpha emitter in
vivo.
Tom Bäck, Stig Palm, Sture Lindegren, Börje Karlsson, Ragnar Hultborn, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2004 -
Cerebral spinal fluid dosimetry following intrathecal injection of I-131-labeled 3F8 antibody in patients with leptomeningeal
tumors.
J Humm, K Kramer, N-K Cheung, Stig Palm, P Zanzonico, K Pentlow, S Yeh, S Larson
Journal of Nuclear Medicine - 2004 -
Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu
expression.
Ase M Ballangrud, Wei-Hong Yang, Stig Palm, Richard Enmon, Paul E Borchardt, Virginia A Pellegrini, Michael R McDevitt, David A Scheinberg, George Sgouros
Clinical cancer research : an official journal of the American Association for Cancer Research - 2004 -
Microdosimetry of astatine-211 single-cell irradiation: role of daughter polonium-211
diffusion.
Stig Palm, John L Humm, Robert Rundqvist, Lars Jacobsson
Medical physics - 2004 -
Mathematical modeling analysis of Ac-225-antibody targeting of disseminated
cancer.
G Sgouros, Stig Palm, J Jaggi, R Enmon, M McDevitt, D Scheinberg
Journal of Nuclear Medicine - 2003 -
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and
MRI.
Stig Palm, Richard M Enmon, Cornelia Matei, Katherine S Kolbert, Su Xu, Pat B Zanzonico, Ronald L Finn, Jason A Koutcher, Steven M Larson, George Sgouros
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2003 -
Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor
model
Håkan Andersson, Jörgen Elgqvist, György Horvath, Ragnar Hultborn, Lars Jacobsson, H. Jensen, Börje Karlsson, Sture Lindegren, Stig Palm
Clin Cancer Res - 2003 -
Single-cell irradiation from [211At] astatine-labeled C215 monoclonal antibody: improved estimates of radiosensitivity from measurements on cellular uptake and
retention
Stig Palm, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Sture Lindegren, Lars Jacobsson
Anticancer Res - 2003 -
Pharmacokinetics of 86Y-Herceptin in an ovarian carcinoma model: correlative microPET and MR
imaging.
Stig Palm, R Enmon, S Xu, C Matei, K Colbert, P Borchardt, P Zanzonico, B Beattie, R Finn, S Larson, J Koutcher, G Sgouros
Journal of Nuclear Medicine - 2002 -
Modeling alpha-emitter labeled anti-PSMA antibody [225Ac-J591] targeting of prostate micrometastases: microdosimetric analysis of spheroid
response.
Stig Palm, R Enmon, D Scheinberg, W Yang, H Scher, V Pellegrini, G Sgouros, N Bander, M McDevitt
Cancer Biotherapy and Radiopharmaceuticals - 2002 -
At-211 labelled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumour
model.
Ragnar Hultborn, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Jörgen Elgqvist, György Horvath, Lars Jacobsson, Holger Jensen, Sture Lindegren, Stig Palm, Elisabet Warnhammar Finnborg
Cancer Biotherapy and Radiopharmaceuticals - 2002 -
Vesicular nanocarriers for targeted alpha-particle therapy of metastatic
cancer.
S Sofou, J Thomas, H Lin, V Pellegrini, Stig Palm, M McDevitt, D Scheinberg, G Sgouros
Cancer Biotherapy and Radiopharmaceuticals - 2002 -
Comparison of hematological toxicity of the alpha emitter 211At and the electron emitter 99mTc in nude
mice.
Jörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn, Börje Karlsson, Sture Lindegren, Stig Palm, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2002 -
Exploring the anticancer potential of the alpha-particle emitter
astatine-211.
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, György Horvath, Ragnar Hultborn, Lars Jacobsson, Börje Karlsson, Sture Lindegren
Anticancer Research - 2001 -
Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian
cancer.
Håkan Andersson, Stig Palm, Sture Lindegren, Tom Bäck, Lars Jacobsson, Gunilla Leser, György Horvath
Anticancer research - 2001 -
Dosimetrical considerations in astatine-211
radioimmunotherapy
Stig Palm, Lars Jacobsson
Therapeutic applications of radiopharmaceuticals. IAEA-TECDOC-1228 - 2001 -
In vitro effects and microdosimetry of 211At for tumour
therapy.
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
International Journal of Radiation Oncology, Biology, Physics - 2000 -
Cell growth kinetics of the human cell line Colo-205 irradiated with photons and astatine-211
alpha-particles
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 2000 -
In vitro effects of free 211At,211At-albumin and 211At-monoclonal antibody compared to external photon irradiation on two human cancer cell
lines
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 2000 -
Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth
assay
Stig Palm, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 1998